Oral contraceptives

口服避孕药
  • 文章类型: Journal Article
    缺血性结肠炎是胃肠道缺血表现的一半以上的原因,并且由于肠血流中断而发展。风险因素包括年龄增加和与灌注减少相关的状况。很少,缺血性结肠炎可能发生在年轻女性处方口服避孕药。这里,我们介绍了一例口服避孕药继发的缺血性结肠炎病例,该病例因停药而消退.
    结论:缺血性结肠炎是由于肠血流量不足引起的,并且是一半胃肠道缺血病例的原因。口服避孕药使缺血性结肠炎的易感发展增加了1.05。症状通常随着口服避孕药的去除而解决。
    Ischaemic colitis is responsible for more than half of the presentations of gastrointestinal ischaemia and develops due to an interruption of intestinal blood flow. Risk factors include increasing age and conditions associated with decreased perfusion. Infrequently, ischaemic colitis may develop in young females prescribed oral contraceptives. Here, we present a case of ischaemic colitis secondary to oral contraceptives that resolved with medication discontinuation.
    CONCLUSIONS: Ischaemic colitis is due to insufficiency of intestinal blood flow and is responsible for half of the cases of gastrointestinal ischaemia.Oral contraceptives have an increased odd of 1.05 predisposing development of ischaemic colitis.Symptoms typically resolve with removal of the oral contraceptive.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    背景/目的:颞下颌关节功能障碍综合征包括几种咀嚼系统疾病,即肌肉,关节本身,以及牙齿和牙周系统。这种综合征的特征通常是疼痛和无法在上颌牙器内执行功能,这会给患者造成一定程度的残疾。女性比男性和荷尔蒙因素更容易患这种综合症,特别是雌激素,是其病因和病理生理学的核心。方法:使用PubMed/MEDLINE进行全面的文献检索,Scopus,Embase,和WebofScience数据库有关2008年1月至2023年12月发表的文章。两位作者基于使用商定的关键字的预先建立的搜索策略在上述数据库中进行搜索。此外,每位综述作者根据既定的纳入标准选择符合条件的研究.使用纽卡斯尔-渥太华量表和偏见风险工具2评估每篇文章的方法学质量。结果:在四个书目数据库中发现的1030条记录中,22项研究纳入本综述。α雌激素受体的多态性似乎在颞下颌关节功能障碍的女性中更为普遍,暗示了遗传倾向.雌激素在TMD相关疼痛的病理生理学中具有重要作用。多囊卵巢综合征(PCOS)患者TMD发病率明显增高,伴有炎症因子升高和孕酮水平降低。在绝经前的女性中,β-雌二醇水平与TMD发展和进展之间存在科学相关性.雌激素对颞下颌关节功能障碍的影响仍然存在争议和挑战性。结论:这些发现强调了考虑激素因素的重要性,遗传易感性,理解和管理颞下颌功能障碍的生殖生命阶段。需要进一步的研究来阐明这些关联的具体机制。
    Background/Objectives: Temporomandibular dysfunction syndrome consists of several disorders of the masticatory system, namely those of the muscles, the joint itself, as well as the dental and periodontal system. This syndrome is often characterized by pain and an inability to perform functions within the dental-maxillary apparatus, which creates a certain degree of disability in patients. Women are more susceptible to this syndrome than men and hormonal factors, particularly estrogen, are central to its etiology and physiopathology. Methods: A comprehensive literature search was conducted using PubMed/MEDLINE, Scopus, Embase, and Web of Science databases regarding articles published from January 2008 to December 2023. Two authors conducted searches in the mentioned databases based on a pre-established search strategy using agreed-upon keywords. Additionally, each review author performed the selection process of eligible studies based on established inclusion criteria. The Newcastle-Ottawa scale and Risk of Bias tool 2 were used to assess each article for its methodological quality. Results: Of the 1030 records found in the four bibliographic databases, 22 studies were included in this review. Polymorphism in the alpha estrogen receptor appears to be significantly more prevalent in women with temporomandibular dysfunction, suggesting a genetic predisposition. There is a significant role of estrogen in the physiopathology of TMD-related pain. Women with polycystic ovary syndrome (PCOS) have a significantly higher incidence of TMD, accompanied by elevated inflammatory factors and decreased progesterone levels. In premenopausal women, there is scientific relevance to the association between beta-estradiol levels and TMD development and progression. The effects of estrogen hormones on temporomandibular dysfunction remain highly debated and challenging. Conclusions: These findings emphasize the importance of considering hormonal factors, genetic predisposition, and reproductive life stages in understanding and managing temporomandibular dysfunction. Further research is needed to elucidate the specific mechanisms underlying these associations.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    背景:宫颈癌是全球女性中第四大最常见的癌症,发展中国家女性发病率高,死亡率高。这项回顾性病例对照研究旨在探讨口服避孕药与宫颈癌之间的关系。证据仍然不足。材料和方法:根据国家健康和营养检查调查的7,496名年龄在20岁以上的女性,研究口服避孕药与宫颈癌之间的关系。使用1999年至2016年进行的多变量逻辑回归。结果:避孕药具的使用与宫颈癌风险呈正相关。在模型1(未调整)中,与未使用口服避孕药的患者相比,使用口服避孕药的患者患宫颈癌的风险增加了195%(比值比[OR]=2.27,95%置信区间[CI]=1.39~3.98,p=0.002).此外,在模型2中,暴露人群的OR分别为1.74(95%CI=1.05-3.08,p=0.041)和1.93(95%CI=1.16-3.44,p=0.017)(调整了年龄,种族,和体重指数[BMI])和模型3(根据教育水平进行了调整,家庭收入与贫困的比率,饮酒状况,吸烟状况,怀孕次数,初次性行为的年龄,性伴侣的数量,以及除了模型2之外是否接受人乳头瘤病毒(HPV)疫苗),分别。此外,按年龄分层的亚组分析,吸烟状况,BMI,初次性行为的年龄,性伴侣的数量,以及是否接种HPV疫苗也表明口服避孕药与宫颈癌显著相关.结论:这项研究表明,口服避孕药的使用增加了宫颈癌的风险。此外,风险越高,包括45岁以上的人,具有高BMI(≥30kg/m2),作为当前的吸烟者,有五个以上的性伴侣,可能有助于宫颈癌的发展。
    Background: Cervical cancer is the fourth most common cancer among females globally, with a high incidence and high mortality among females in developing countries. This retrospective case-control study aimed to investigate the association between oral contraceptives and cervical cancer, on which insufficient evidence still exists. Material and Methods: To examine the association between oral contraceptives and cervical cancer based on 7,496 females aged over 20 years from the National Health and Nutrition Examination Survey, multivariable logistic regression conducted from 1999 to 2016 was used. Results: Contraceptive use was positively associated with cervical cancer risk. In model 1 (unadjusted), a 195% increased risk of cervical cancer was observed among those who used oral contraceptives (odds ratio [OR] = 2.27, 95% confidence interval [CI] = 1.39-3.98, p = 0.002) compared to those who did not. In addition, the ORs for the exposed population were 1.74 (95% CI = 1.05-3.08, p = 0.041) and 1.93 (95% CI = 1.16-3.44, p = 0.017) in model 2 (adjusted for age, race, and body mass index [BMI]) and model 3 (adjusted for education level, ratio of family income to poverty, drinking status, smoking status, number of pregnancies, age at first sex, number of sexual partners, and whether to receive the human papillomavirus (HPV) vaccine in addition to model 2), respectively. Furthermore, subgroup analyses stratified by age, smoking status, BMI, age at first sex, number of sexual partners, and whether to receive the HPV vaccine also revealed that oral contraceptives were significantly associated with cervical cancer. Conclusion: This study demonstrated that oral contraceptive use increased the risk of cervical cancer. In addition, the higher risk, including individuals older than 45 years, having a high BMI (≥30 kg/m2), being current smokers, and having more than five sexual partners, may contribute to the development of cervical cancer.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    TikTok已越来越成为有关生殖健康的信息来源。在TikTok上寻求有关口服避孕药的健康信息的患者可能会受到包含错误信息或偏见信息的视频的影响。
    这项社交媒体信息流行病学研究旨在对TikTok上的口服避孕药健康信息的质量和可靠性进行描述性内容分析。
    研究人员筛选了从2022年12月至2023年3月的1000个TikTok视频,这些视频是在与口服避孕药相关的各种搜索词下检索的。数据,包括参与度指标,如视图,喜欢,注释,保存,和股份,被记录下来。视频内容包括讨论的避孕方法,功效,耐受性,并记录副作用。两名审阅者独立使用修改后的DISCERN标准和全球质量量表(GQS)来评估每个视频的信息质量和可靠性。
    在应用排除标准后分析了五百七十四个视频。视频的中值长度为27秒(Q1=13秒,Q3=57秒),并获得了35,000个总视图的中位数(Q1=4856个视图,Q3=411,400次)和每天166次(Q1=每天28次,Q3=2021年每日观看次数)。视频创作者为83.3%的女性和58.7%的白人。平均改良DISCERN评分为1.63(SD=1.06),平均GQS评分为2.28(SD=1.37)。视频创作者为83.3%的女性和58.7%的白人。平均改良DISCERN评分为1.63(SD=1.06),平均GQS评分为2.28(SD=1.37)。视频中讨论的最常见的话题是避孕的效果。医疗保健专业人员的DISCERN和GQS评分(p<.001)明显高于非医疗保健专业人员。然而,他们收到的观点较少,喜欢,并对他们的视频发表评论(p<.001)。医疗保健专业人员发布教育视频的可能性是非医疗保健专业人员的86倍(p<.001)。然而,非教育内容获得了更多的观点,喜欢,和评论比教育内容(p<.001)。
    与口服避孕药健康相关的TikTok视频的信息质量和可靠性较低。大多数视频是由非医疗保健提供者制作的,最常见的话题是避孕的效果。医疗保健专业人员制作的视频包含更可靠的避孕信息,但获得的参与度低于非医疗保健专业人员制作的视频。在为患者提供生殖健康咨询和教育时,医疗保健提供者应考虑社交媒体上有关口服避孕药的低质量信息的普遍性。
    UNASSIGNED: TikTok has increasingly become a source of information about reproductive health. Patients seeking health information about oral contraception on TikTok may be influenced by videos containing misinformation or biased information.
    UNASSIGNED: This social media infodemiological study aims to provide a descriptive content analysis of the quality and reliability of oral contraceptive health information on TikTok.
    UNASSIGNED: Researchers screened 1,000 TikTok videos from December 2022 to March 2023 retrieved under various search terms related to oral contraceptives. Data, including engagement metrics such as views, likes, comments, saves, and shares, were recorded. Video content including contraceptive methods discussed, efficacy, tolerability, and side effects were recorded. Two reviewers independently used a modified DISCERN criteria and Global Quality Scale (GQS) to assess the quality and reliability of information for each video.
    UNASSIGNED: Five hundred seventy-four videos were analyzed after applying exclusion criteria. Videos had a median length of 27 seconds (Q1=13sec, Q3=57sec) and received a median of 35,000 total views (Q1=4856 views, Q3=411,400 views) and 166 views per day (Q1=28 views per day, Q3=2021 views per day). Video creators were 83.3% female and 58.7% white. The mean modified DISCERN score was 1.63 (SD=1.06) and the mean GQS score was 2.28 (SD=1.37). Video creators were 83.3% female and 58.7% white. The mean modified DISCERN score was 1.63 (SD=1.06) and the mean GQS score was 2.28 (SD=1.37). The most common topic discussed in the videos was the effects of contraception. Healthcare professionals had significantly higher DISCERN and GQS scores (p<.001) than non-healthcare professionals. However, they received fewer views, likes, and comments on their videos (p<.001). Healthcare professionals were 86 times more likely than non-healthcare professionals to post educational videos (p<.001). However, non-educational content received significantly more views, likes, and comments than educational content (p<.001).
    UNASSIGNED: TikTok videos related to oral contraceptive health had low quality and reliability of information. The majority of videos were made by non-healthcare providers, and the most common topic discussed was the effects of contraception. Videos made by healthcare professionals contained more reliable contraceptive information, but received less engagement than videos made by non-healthcare professionals. Healthcare providers should consider the prevalence of poor-quality information about oral contraceptives on social media when counseling and educating patients about reproductive health.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    背景:全球超过4亿育龄妇女使用处方避孕。监测避孕药具的使用是一个主要的公共卫生问题,通常依赖于基于人群的调查。然而,这些调查平均每6年进行一次,不允许对避孕药具的使用进行密切随访。此外,他们的样本量通常太有限,无法研究特定的人群亚组,如低收入人群。卫生行政数据可能是研究避孕药具使用的创新且成本较低的来源。
    目的:我们旨在探索卫生管理数据在研究处方避孕药具使用方面的潜力,并将这些数据与基于调查数据的观察结果进行比较。
    方法:我们选择了所有15-49岁的女性,由法国健康保险覆盖并居住在法国,在卫生行政数据库中,占常住人口的98%(n=14,788,124),在上一次法国人口代表性调查中,健康晴雨表调查,2016年进行(n=4285)。在卫生行政数据中,记录了避孕药具的使用情况,并提供了有关产品的详细信息,而在调查中,这是由妇女自己宣布的。在这两个来源中,对所有处方避孕药具和避孕药具类型的全球避孕药具使用率进行了估计:口服避孕药,宫内节育器(IUD),和植入物。按年龄分析了患病率。
    结果:卫生行政数据中的低收入妇女多于基于人口的调查(1,576,066/14,770,256,11%vs188/4285,7%,分别;P<.001)。在卫生行政数据中,在基于人群的调查中,有47.6%(7034,710/14,770,256;95%CI47.6%-47.7%)的15-49岁女性使用了处方避孕药,而50.5%(2297/4285;95%CI49.1%-52.0%)。考虑到卫生行政数据与调查数据中避孕药具类型的患病率,口服避孕药分别为26.9%(95%CI26.9%-26.9%)和27.7%(95%CI26.4%-29.0%),宫内节育器的17.7%(95%CI17.7%-17.8%)与19.6%(95%CI18.5%-20.8%),和3%(95%CI3.0%-3.0%)与3.2%(95%CI2.7%-3.7%)的植入物。在这两个来源中,这3种避孕药具的总体流行趋势相同.植入物在各个年龄段都很少使用,口服避孕药在年轻女性中使用率很高,而年轻女性的宫内节育器使用率较低。
    结论:与调查数据相比,卫生行政数据显示口服避孕药的总体趋势相同,宫内节育器,和植入物。卫生行政数据的主要优势之一是关于避孕药具使用的高质量信息和大量的观察,允许研究人口的亚组。因此,卫生行政数据似乎是以人口为基础的方法监测避孕的有希望的新来源。它们可以为研究开辟新的视角,并成为指导生殖健康和性健康公共政策的宝贵新资产。
    BACKGROUND: Prescribed contraception is used worldwide by over 400 million women of reproductive age. Monitoring contraceptive use is a major public health issue that usually relies on population-based surveys. However, these surveys are conducted on average every 6 years and do not allow close follow-up of contraceptive use. Moreover, their sample size is often too limited for the study of specific population subgroups such as people with low income. Health administrative data could be an innovative and less costly source to study contraceptive use.
    OBJECTIVE: We aimed to explore the potential of health administrative data to study prescribed contraceptive use and compare these data with observations based on survey data.
    METHODS: We selected all women aged 15-49 years, covered by French health insurance and living in France, in the health administrative database, which covers 98% of the resident population (n=14,788,124), and in the last French population-based representative survey, the Health Barometer Survey, conducted in 2016 (n=4285). In health administrative data, contraceptive use was recorded with detailed information on the product delivered, whereas in the survey, it was self-declared by the women. In both sources, the prevalence of contraceptive use was estimated globally for all prescribed contraceptives and by type of contraceptive: oral contraceptives, intrauterine devices (IUDs), and implants. Prevalences were analyzed by age.
    RESULTS: There were more low-income women in health administrative data than in the population-based survey (1,576,066/14,770,256, 11% vs 188/4285, 7%, respectively; P<.001). In health administrative data, 47.6% (7034,710/14,770,256; 95% CI 47.6%-47.7%) of women aged 15-49 years used a prescribed contraceptive versus 50.5% (2297/4285; 95% CI 49.1%-52.0%) in the population-based survey. Considering prevalences by the type of contraceptive in health administrative data versus survey data, they were 26.9% (95% CI 26.9%-26.9%) versus 27.7% (95% CI 26.4%-29.0%) for oral contraceptives, 17.7% (95% CI 17.7%-17.8%) versus 19.6% (95% CI 18.5%-20.8%) for IUDs, and 3% (95% CI 3.0%-3.0%) versus 3.2% (95% CI 2.7%-3.7%) for implants. In both sources, the same overall tendency in prevalence was observed for these 3 contraceptives. Implants remained little used at all ages, oral contraceptives were highly used among young women, whereas IUD use was low among young women.
    CONCLUSIONS: Compared with survey data, health administrative data exhibited the same overall tendencies for oral contraceptives, IUDs, and implants. One of the main strengths of health administrative data is the high quality of information on contraceptive use and the large number of observations, allowing studies of subgroups of population. Health administrative data therefore appear as a promising new source to monitor contraception in a population-based approach. They could open new perspectives for research and be a valuable new asset to guide public policies on reproductive and sexual health.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    本研究旨在评估口服避孕药(OC)的使用效果,Khat咀嚼,以及它们对端粒酶水平和抑癌基因的联合作用,p53和p21在乳腺癌(BC)患者和正常志愿者中的表达。140名25-40岁的也门妇女入学,60例新诊断的治疗前的BC患者,和80个对照对象。收集静脉血(5ml),结果显示BC患者端粒酶水平明显升高,p53和p21与对照组比较。对照组使用OC显着提高了端粒酶,但对BC患者没有影响;而BC患者中p53和p21显着增加。另一方面,在对照组和BC患者中咀嚼Khat显着增加p53,而BC患者p21显著升高。联合使用OC和khat咀嚼可显著增加对照组的端粒酶和p53,并且在BC患者中p53和p21明显增加。端粒酶被证明是BC的危险因素(OR4.4),在正常受试者中,使用OC是端粒酶升高的高风险因素(OR27.8)。相比之下,Khat咀嚼被证明是保护性的(OR0.142),OCs和khat咀嚼的联合使用使端粒酶的危险因素从OR27.8降至2.1。
    This study aimed to evaluate the effects of oral contraceptive (OC) use, khat chewing, and their combined effect on telomerase level and tumor suppressor genes, p53 and p21 in breast cancer (BC) patients and normal volunteers. 140 Yemeni women aged 25-40 years old enrolled, 60 newly diagnosed pretreated BC patients, and 80 control subjects. Venous blood (5 ml) was collected and the results showed BC patients to have significantly raised levels of telomerase, p53, and p21 compared to the control group. The use of OCs significantly raised telomerase in control group with no effect in BC patients; whereas p53 and p21 were significantly increased in BC patients. On the other hand, khat chewing significantly increased p53 in controls and BC patients, whereas p21 was significantly raised in BC patients. The combined use of OCs and khat chewing significantly increased telomerase and p53 in control group, and significantly increased p53 and p21 in BC patients. Telomerase was shown to be a risk factor (OR 4.4) for BC, and the use of OCs was a high-risk factor for increasing telomerase (OR 27.8) in normal subjects. In contrast, khat chewing was shown to be protective (OR 0.142), and the combined use of OCs and khat chewing decreased the risk factor of telomerase from OR 27.8 to 2.1.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    先前的研究表明,口服避孕药(OC)使用者对手臂代谢反射激活的心肺反应增强(即,运动后循环阻塞,PECO)和与非OC用户(NOC)相比,对腿部被动运动(PM)的压缩响应减弱。我们调查了32名女性对手臂或腿部代谢反射和机械反射激活的心肺反应(OC,n=16;NOC,n=16)进行四次试验:40%的手握或80%的屈,然后是PECO和手臂或腿部PM。OC和NOC增加平均动脉压(MAP)相似,与基线相比,前屈和臂/腿PECO。尽管在运动期间增加了通风(VE),没有女性在手臂或腿部PECO时表现出更高的VE。与基线相比,OC和NOC在手臂或腿部PM期间类似地增加MAP和VE。因此,OC和NOC对手臂或腿部代谢反射和机械反射激活的升压和通气反应相似。然而,由于OC引起的一些差异可能被肌肉力量的差异所掩盖。由于女性在运动中增加了VE,我们建议,虽然女性对代谢反射激活没有通气反应(可能是由于未达到刺激VE的理论代谢物阈值),在女性运动期间,机械反射可能会驱动VE。
    Previous research has demonstrated that oral contraceptive (OC) users have enhanced cardiorespiratory responses to arm metaboreflex activation (i.e., postexercise circulatory occlusion, PECO) and attenuated pressor responses to leg passive movement (PM) compared to non-OC users (NOC). We investigated the cardiorespiratory responses to arm or leg metaboreflex and mechanoreflex activation in 32 women (OC, n = 16; NOC, n = 16) performing four trials: 40% handgrip or 80% plantarflexion followed by PECO and arm or leg PM. OC and NOC increased mean arterial pressure (MAP) similarly during handgrip, plantarflexion and arm/leg PECO compared to baseline. Despite increased ventilation (VE) during exercise, none of the women exhibited higher VE during arm or leg PECO. OC and NOC similarly increased MAP and VE during arm or leg PM compared to baseline. Therefore, OC and NOC were similar across pressor and ventilatory responses to arm or leg metaboreflex and mechanoreflex activation. However, some differences due to OC may have been masked by disparities in muscle strength. Since women increase VE during exercise, we suggest that while women do not display a ventilatory response to metaboreflex activation (perhaps due to not reaching a theoretical metabolite threshold to stimulate VE), the mechanoreflex may drive VE during exercise in women.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    全球数以亿计的人使用激素避孕药(HCs),几十年来,这一直是妇女生殖保健的重要组成部分。在这段时间里,然而,对HCs的神经和行为后果的研究很少,而且方法论很差。HC效应-和用户-被认为是同质的。幸运的是,最近调查的数量和质量都有所上升,提供关于HCs在空间认知和心理健康中的作用的初步结论,尤其是抑郁症。因此,本文利用过去几年的研究结果来强调似乎对行为有影响的异质性使用方面-从激素避孕配方和给药途径的变化到使用者之间与年龄和生殖健康史相关的个体差异。本文以未来研究的五个提示结束,这些提示将有助于捕获和阐明HCs与行为之间潜在关系的异质性,即数据收集,区域访问,寿命因素,性别,和合作。HCs具有社会政治挑衅性,对其潜在行为神经内分泌影响的研究越来越受欢迎。是的,因此,科学家必须进行可复制和强有力的实证研究,并将发现与用户和效果之间的异质性所需的细微差别进行沟通。
    Hundreds of millions of people worldwide use hormonal contraceptives (HCs), which have been an essential part of women\'s reproductive health care for decades. Throughout that time, however, research on the neural and behavioral consequences of HCs was minimal and plagued by poor methodology. HC effects - and users - were assumed to be homogenous. Fortunately, there has been a recent upswell in the number and quality of investigations, affording tentative conclusions about the roles of HCs in spatial cognition and mental health, particularly depression. Thus, this paper leverages findings from the past few years to highlight the heterogeneous aspects of use that seem to matter for behavior - ranging from variation in hormonal contraceptive formulations and routes of administration to individual differences among users linked to age and reproductive health history. This paper closes with five tips for future research that will help capture and clarify heterogeneity in potential relations between HCs and behavior, namely data collection, regional access, lifespan factors, gender, and collaboration. HCs are sociopolitically provocative and research on their potential behavioral neuroendocrine impacts is becoming increasingly popular. It is, therefore, imperative for scientists to conduct replicable and robust empirical investigations, and to communicate findings with the nuance that the heterogeneity among users and effects requires.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • DOI:
    文章类型: Journal Article
    痤疮是世界范围内皮肤的常见炎症。皮肤是一种内分泌器官,激素是所有类型痤疮的关键致病因素,在成年女性痤疮的发病和治疗中起着特别重要的作用。在女性中,我们有独特的机会来操纵激素系统成功地管理痤疮,最近,随着克拉昔克龙1%霜的批准,我们可以针对两种性别的激素。本文的目的是为医生提供有关激素在痤疮中的作用的最新临床相关综述,目前可用的避孕药具和可用的治疗对痤疮靶向激素的影响。
    Acne is a common inflammatory condition of the skin worldwide. The skin is an endocrine organ and hormones are a key pathogenic factor in all types of acne with a particularly important role in adult female acne pathogenesis and management. In females, we have the unique opportunity to manipulate hormones systemically to successfully manage acne and, more recently with the approval of clascoterone 1% cream, we can target the hormones topically in both genders. The intent of this paper is to provide physicians with an up-to-date clinically relevant review of the role of hormones in acne, the impact of currently available contraceptives and therapies available to target hormones in acne.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    最近的研究越来越多地承认口服避孕药对情感行为和应激反应的影响;然而,潜在的机制仍然没有得到很好的理解。先前的研究表明,类固醇激素可以调节自动接近和回避行为。这里,因此,我们研究了口服避孕药对接近和回避行为的影响,以及这些影响是否受到压力的调节。这项研究包括130名女性参与者,其中一半使用口服避孕药,而另一半没有使用任何激素避孕(NC)。参与者完成了方法回避任务(AAT),测量对社会情感信号的自动接近和回避行为。在压力操作之前和之后使用社会评估的冷压测试运行AAT一次。OC用户对社会威胁信号没有回避行为,而对积极社会信号的接近行为则由压力引起。后者尤其在服用雄激素作用OC的女性中发现,证明在研究OC效应时需要考虑不同的OC制剂。然而,OC组和NC组在皮质醇应激反应方面没有差异。总的来说,结果表明,OC的使用会影响对社会信号的接近和回避行为,这也可能有助于情感副作用的发展。
    Recent research has increasingly acknowledged the impact of oral contraceptives on affective behavior and stress responses; however, the underlying mechanisms are still not well understood. Studies have previously shown that steroid hormones modulate automatic approach and avoidance behavior. Here, we thus investigated the effects of oral contraceptives on approach and avoidance behavior and whether these effects are modulated by stress. The study comprised 130 female participants, half of whom were using oral contraceptives, while the other half were not using any hormonal contraception (NC). The participants completed the Approach Avoidance Task (AAT), which measures automatic approach and avoidance behavior to socio-affective signals. The AAT was run once before and once after a stress manipulation using the Socially Evaluated Cold Pressor Test. OC users showed absent avoidance behavior to social threat signals and a stress-induced increase in approach behavior to positive social signals. The latter was found in particular in women taking androgenic acting OC, demonstrating that different OC preparations need to be taken into account in research on OC effects. However, OC and NC group did not differ in their cortisol stress response. Overall, the results suggest that OC usage impacts on approach and avoidance behavior to social signals, which might also contribute to the development of affective side effects.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

公众号